Featured Clinical Trials Supported by the National Cancer Institute
Today, hundreds of cancer clinical trials are under way in the United States. Clinical trials answer vital research questions that lead to better screening, prevention, diagnosis, and treatment options for all cancers. This section highlights just a few of the NCI-supported cancer trials currently enrolling participants.
To find other cancer trials open to enrollment:
- Call the National Cancer Institute’s Cancer Information Service at 1-800-4-CANCER (1-800-422-6237) for information about trials all across the country. The call is toll-free and completely confidential.
- Use the basic PDQ search form to look online for trials listed in NCI's clinical trials database. The top of the form has a Help link for tips about searching for clinical trials.
- For information about cancer trials taking place on the National Institutes of Health campus in Bethesda, Maryland, call the National Cancer Institute’s Clinical Studies Support Center at 1-888-NCI-1937 (1-888-624-1937). The call is toll-free and completely confidential.
1. Immunotherapy for Patients with Metastatic Melanoma
(Posted: 10/12/2004) - With this trial, researchers are testing the safety and tumor-fighting ability of a new type of immunotherapy agent in patients with metastatic melanoma that has not responded to standard treatment.
2. Comparison of Chemotherapy Combinations for Colon Cancer
(Posted: 10/05/2004) - Researchers with this study are comparing six different chemotherapy and biological therapy regimens for stage III colon cancer following surgery.
3. Immunotoxin Therapy for Advanced Solid Tumors
(Posted: 09/21/2004) - Researchers with this trial will test the safety of a new drug called SS1(dsFv)-PE38 (SS1P) in patients who have advanced mesothelin-expressing cancers.
4. Study of Individuals and Families at High Risk for Melanoma
(Posted: 09/14/2004) - Researchers with this study are seeking members of families in which there are multiple cases of melanoma to identify genes and precursor conditions that may increase the likelihood of developing this disease.
5. Prevention of Bone Fractures in Prostate Cancer Patients
(Posted: 09/07/2004) - This study will evaluate the ability of zoledronate (Zometa®), one of a family of drugs known as bisphosphonates, to prevent fractures and other bone complications when administered at the same time as or shortly following androgen deprivation therapy.
1 2 3 4 Next >
|
